Leyden WA - Search Results

1

Differences in COVID-19 testing and adverse outcomes by race, ethnicity, sex, and health system setting in a large diverse US cohort.

Jefferson C, Watson E, Certa JM, Gordon KS, Park LS, D'Souza G, Benning L, Abraham AG, Agil D, Napravnik S, Silverberg MJ, Leyden WA, Skarbinski J, Williams C, Althoff KN, Horberg MA; NA-ACCORD Corona-Infectious-Virus Epidemiology Team (CIVET). Jefferson C, et al. Among authors: leyden wa. PLoS One. 2022 Nov 23;17(11):e0276742. doi: 10.1371/journal.pone.0276742. eCollection 2022. PLoS One. 2022. PMID: 36417366 Free PMC article.

2

Older age and the response to and tolerability of antiretroviral therapy.

Silverberg MJ, Leyden W, Horberg MA, DeLorenze GN, Klein D, Quesenberry CP Jr. Silverberg MJ, et al. Arch Intern Med. 2007 Apr 9;167(7):684-91. doi: 10.1001/archinte.167.7.684. Arch Intern Med. 2007. PMID: 17420427

3

Response to newly prescribed lipid-lowering therapy in patients with and without HIV infection.

Silverberg MJ, Leyden W, Hurley L, Go AS, Quesenberry CP Jr, Klein D, Horberg MA. Silverberg MJ, et al. Ann Intern Med. 2009 Mar 3;150(5):301-13. doi: 10.7326/0003-4819-150-5-200903030-00006. Ann Intern Med. 2009. PMID: 19258558

4

Race/ethnicity and risk of AIDS and death among HIV-infected patients with access to care.

Silverberg MJ, Leyden W, Quesenberry CP Jr, Horberg MA. Silverberg MJ, et al. J Gen Intern Med. 2009 Sep;24(9):1065-72. doi: 10.1007/s11606-009-1049-y. Epub 2009 Jul 16. J Gen Intern Med. 2009. PMID: 19609624 Free PMC article.

5

HIV infection and the risk of cancers with and without a known infectious cause.

Silverberg MJ, Chao C, Leyden WA, Xu L, Tang B, Horberg MA, Klein D, Quesenberry CP Jr, Towner WJ, Abrams DI. Silverberg MJ, et al. Among authors: leyden wa. AIDS. 2009 Nov 13;23(17):2337-45. doi: 10.1097/QAD.0b013e3283319184. AIDS. 2009. PMID: 19741479 Free PMC article.

6

Survival of non-Hodgkin lymphoma patients with and without HIV infection in the era of combined antiretroviral therapy.

Chao C, Xu L, Abrams D, Leyden W, Horberg M, Towner W, Klein D, Tang B, Silverberg M. Chao C, et al. AIDS. 2010 Jul 17;24(11):1765-70. doi: 10.1097/QAD.0b013e32833a0961. AIDS. 2010. PMID: 20453630 Free PMC article.

7

HMG-CoA reductase inhibitors (statins) use and risk of non-Hodgkin lymphoma in HIV-positive persons.

Chao C, Xu L, Abrams DI, Towner WJ, Horberg MA, Leyden WA, Silverberg MJ. Chao C, et al. Among authors: leyden wa. AIDS. 2011 Sep 10;25(14):1771-7. doi: 10.1097/QAD.0b013e328349c67a. AIDS. 2011. PMID: 21681055 Free PMC article.

8

Effect of once-daily FDC treatment era on initiation of cART.

Mosen DM, Horberg M, Roblin D, Gullion CM, Meenan R, Leyden W, Hu W. Mosen DM, et al. HIV AIDS (Auckl). 2010;2:19-26. doi: 10.2147/hiv.s8803. Epub 2010 Feb 15. HIV AIDS (Auckl). 2010. PMID: 22096381 Free PMC article.

9

HIV infection, immunodeficiency, viral replication, and the risk of cancer.

Silverberg MJ, Chao C, Leyden WA, Xu L, Horberg MA, Klein D, Towner WJ, Dubrow R, Quesenberry CP Jr, Neugebauer RS, Abrams DI. Silverberg MJ, et al. Among authors: leyden wa. Cancer Epidemiol Biomarkers Prev. 2011 Dec;20(12):2551-9. doi: 10.1158/1055-9965.EPI-11-0777. Epub 2011 Nov 22. Cancer Epidemiol Biomarkers Prev. 2011. PMID: 22109347 Free PMC article.

10

The effect of HIV infection, immunodeficiency, and antiretroviral therapy on the risk of hepatic dysfunction.

Towner WJ, Xu L, Leyden WA, Horberg MA, Chao CR, Tang B, Klein DB, Hurley LB, Quesenberry CP Jr, Silverberg MJ. Towner WJ, et al. Among authors: leyden wa. J Acquir Immune Defic Syndr. 2012 Jul 1;60(3):321-7. doi: 10.1097/QAI.0b013e31824e9ef2. J Acquir Immune Defic Syndr. 2012. PMID: 22343179 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

65 results

Search Page